Ischemic-type biliary lesions (ITBLs) are the most frequent cause of nonanastomotic
biliary strictures in liver grafts, affecting about 2-19 % of patients after liver
transplantation. ITBL is characterized by bile duct destruction, subsequent stricture
formation, and sequestration. We report here the case of a patient affected by extremely
severe ITBL, with sequestration and disintegration of the entire bile duct system,
in which it was possible to extract the complete biliary tree endoscopically in a
single piece. Histological examination revealed that all cells of the bile duct wall
had been destroyed within 3 months after liver transplantation and replaced by connective
tissue. Subsequently, biliary stricture formation occurred at the hepatic hilum, as
well as the adjacent large bile ducts. It may be hypothesized that cellular rejection
of small bile ducts leads to the vanishing bile duct syndrome, whereas cellular rejection
of large bile ducts results in ITBL. The strictures were repeatedly dilated by endoscopic
means, allowing successful control of stricture formation, as well as maintenance
of liver function. At the time of writing, the grafted organ and the patient had survived
for more than 3 years in good health. This is the first detailed report on a sequestration
of the entire bile duct system caused by ITBL, successfully treated for several years
by endoscopic means.
References
1
Hintze R E, Abou-Rebyeh H, Adler A. et al .
Endoscopic therapy of ischemic-type biliary lesions (ITBL) in patients after orthotopic
liver transplantation.
Z Gastroenterol.
1999;
37
13-20
2
Sanchez Urdazpal L, Gores G J, Ward E M. et al .
Diagnostic features and clinical outcome of ischemic-type biliary complications after
liver transplantation.
Hepatology.
1993;
17
605-609
3
Fisher A, Miller C H.
Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited?.
Hepatology.
1995;
21
589-591
4
Nakamura K, Murase N, Becich M J. et al .
Liver allograft rejection in sensitized recipients: observations in a clinically relevant
small animal model.
Am J Pathol.
1993;
142
1383-1391
5
Sanchez Urdazpal L, Batts K P, Gores G J. et al .
Increased bile duct complications in liver transplantation across the ABO barrier.
Ann Surg.
1993;
218
152-158
6
Schlitt H J, Meier P N, Nashan B. et al .
Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after
liver transplantation.
Ann Surg.
1999;
229
137-145
7
Sebagh M, Farges O, Kalil A. et al .
Sclerosing cholangitis following human orthotopic liver transplantation.
Am J Surg Pathol.
1995;
19
81-90
8
Johnson M W, Thompson P, Meehan A. et al .
Internal biliary stenting in orthotopic liver transplantation.
Liver Transpl.
2000;
6
356-361
9
Davidson B R, Rai R, Kurzawinski T R. et al .
Prospective randomized trial of end-to-end versus side-to-side biliary reconstruction
after orthotopic liver transplantation.
Br J Surg.
1999;
86
447-452
10
Wiesner R H.
Advances in diagnosis, prevention, and management of hepatic allograft rejection.
Clin Chem.
1994;
40
2174-2185
11
Baron P W, Heneghan M A, Suhocki P V. et al .
Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation.
Liver Transpl.
2001;
7
62-67
12
Seiler C A, Renner E L, Czerniak A. et al .
Early acute cellular rejection: no effect on late hepatic allograft function in man.
Transpl Int.
1999;
12
195-201
13
Wiesner R H, Ludwig J, van Hoek B, Krom R AF.
Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia
and liver failure.
Hepatology.
1991;
14
721-728
14
Tan C E, Vijayan V.
New clues for the developing human biliary system at the porta hepatis.
J Hepatobiliary Pancreat Surg.
2001;
8
295-302
15
Mahajani R V, Cotler S J, Uzer M F.
Efficacy of endoscopic management of anastomotic biliary strictures after hepatic
transplantation.
Endoscopy.
2000;
32
943-949
H. Abou-Rebyeh, M. D.
Dept. of Hepatology, Gastroenterology, Endocrinology and Metabolism ·
University Hospital Charité, Campus Virchow-Klinikum · Humboldt University · Augustenburger
Platz 1 · 13353 Berlin · Germany
Fax: +49 30 450 553 917
Email: Hassan.Abou-Rebyeh@charite.de